Charles River Laboratories | أصول متداولة



Current Assets تغيير تاريخ
Agilent USD 4.21B 101M 2025-04
Align Technology USD 2.45B 46.03M 2025-06
Bio-Rad Laboratories USD 2.81B 225.5M 2025-06
Bruker USD 2.16B 51.2M 2025-06
Cardinal Health USD 36.37B 1.78B 2025-06
Charles River Laboratories USD 1.47B 36.5M 2025-06
Cigna USD 44.72B 1.17B 2025-06
CVS Health USD 75.65B 2.46B 2025-06
Danaher USD 11B 1.47B 2025-06
Dentsply International USD 1.97B 12M 2025-06
Elevance Health 63.32B 2.2B 2025-06
Galapagos EUR 3.26B 217.04M 2025-06
Hologic USD 3.42B 212.7M 2025-06
Humana USD 34.42B 4.61B 2025-03
Illumina USD 2.64B 32M 2025-06
Incyte USD 3.64B 411.91M 2025-06
IQVIA Holdings USD 6.35B 434M 2025-06
Laboratory Of America USD 4.09B 297.5M 2025-06
Lonza CHF 5.44B 113M 2024-12
McKesson USD 56.8B 1.4B 2025-06
Merck EUR 12.2B 216M 2025-06
Mettler Toledo International USD 1.24B 79.67M 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Quest Diagnostics USD 2.2B 123M 2025-06
Revvity USD 2.24B 81.76M 2025-06
Thermo Fisher Scientific USD 24.58B 1.21B 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06
UnitedHealth 96.29B 10.51B 2025-03
Walgreens Boots Alliance USD 15.7B 536M 2025-05
Waters USD 1.78B 42.24M 2025-06
West Pharmaceutical Services USD 1.68B 223.4M 2025-06


Charles River Laboratories أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.